U.S. markets closed

BIMI International Medical, Inc. (BIMI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.0893+0.0793 (+3.95%)
At close: 03:58PM EST
2.0207 -0.07 (-3.28%)
After hours: 07:54PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close2.0100
Bid2.0000 x 900
Ask2.0800 x 1800
Day's Range2.0000 - 2.1700
52 Week Range0.4800 - 3.5000
Avg. Volume17,807
Market Cap13.768M
Beta (5Y Monthly)0.90
PE Ratio (TTM)N/A
EPS (TTM)-7.0600
Earnings DateDec 11, 2023 - Dec 22, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for BIMI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BIMI International Medical Inc.
    Daily – Vickers Top Buyers & Sellers for 12/07/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • GlobeNewswire

    BIMI Announces Buyback of Warrants

    NEW YORK, NY, Nov. 28, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI, "BIMI"), a healthcare products and services provider, today announced its entry into material definitive agreements with certain of its warrant holders, pursuant to which BIMI agreed to buy back an aggregate of 7,066,913 warrants to purchase shares of common stock of the Company from these warrant holders. BIMI agreed to pay $0.30 for each share of common stock underlying the warrant, or an aggregate p

  • GlobeNewswire

    BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)

    NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”) today announced that on November 21, 2023, the Company received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Third Quarter Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires lis

  • GlobeNewswire

    BIMI International Medical Inc. Announces Second Quarter 2023 Financial Results

    NEW YORK, Nov. 27, 2023 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (the “Company”), a leading medical solutions provider, today announced its financial results for the three months ended June 30, 2023. The Company reported a significant increase in gross margin underlining the ongoing success of its business strategy and operational effectiveness. Revenues for the six months ended June 30, 2023 and 2022 were $8,755,303 and $5,543,745, respectively. Compared with the same period in 2022,